Sign in
AEMD Stock Price, Chart, Stats & News
Aethlon Medical, Inc.
Save
Aethlon Medical, Inc. (AEMD) does not currently pay a dividend.
645,795
Market cap
–
Current P/E
0.21x
Forward P/E
AEMD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -143.00% |
ROE | -219.40% |
D/E | 0.06x |
Interest coverage ratio | -728.89x |
AEMD valuation
P/E | – |
P/S | – |
P/B | 0.26x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.02x |
EV multiple | -0.74x |
About
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses.
Similar securities
Based on sector and market capitalization
Report issue